CivicKnodeCivicKnowA project of CivicKnode
Sign in

SB 575

WithdrawnCrossfile HB 517
Add to calendar

Drug Manufacturers - Drug Take-Back Programs (Take It Back Maryland Act)

Sponsor: Karen Lewis Young (District 3)Committee: FinanceSubject: Public HealthStatus: Unfavorable Report by Finance; Withdrawn (as of Nov 9, 2023)

What this bill does

Official synopsis

Requiring manufacturers of certain drugs to operate a certain drug take-back program or enter into a certain agreement with a drug take-back organization or the Maryland Department of Health, in conjunction with the Department of the Environment; requiring the Maryland Department of Health, in conjunction with the Department of the Environment, to determine whether a drug take-back program complies with certain requirements and to provide notification of its determination within a certain time period; etc.

AI analysis is off. Set ANTHROPIC_API_KEY to enable summaries, pros and cons, and questions.

Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.

Testimony (0)

MGA witness list
No witness list on file because no hearing has been scheduled.